Autolus Therapeutics Ownership | Who Owns Autolus Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Autolus Therapeutics Ownership Summary

Autolus Therapeutics is owned by 67.03% institutional investors, 18.09% insiders, and 14.89% retail investors. Syncona portfolio is the largest institutional shareholder, holding 9.61% of AUTL shares. Syncona Ord is the top mutual fund, with 11.55% of its assets in Autolus Therapeutics shares.

AUTL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Autolus Therapeutics	67.03%	18.09%	14.89%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Syncona portfolio	21.35M	9.61%	$74.29M
Blackstone	20.49M	9.22%	$71.29M
Wellington management group llp	17.89M	8.05%	$62.26M
Deep track capital, lp	15.27M	6.87%	$53.15M
Avoro capital advisors	12.35M	5.56%	$42.96M
Fmr	12.30M	5.53%	$42.79M
Tfg asset management gp	8.00M	3.60%	$27.84M
Armistice capital	6.25M	2.81%	$21.75M
Frazier life sciences management	4.62M	2.08%	$16.09M
Blackrock	4.44M	2.00%	$15.44M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Syncona portfolio	21.35M	86.51%	$74.29M
Tfg asset management gp	8.00M	6.94%	$27.84M
Great point partners	3.44M	2.29%	$11.98M
Affinity asset advisors	4.30M	1.72%	$14.96M
Deep track capital, lp	15.27M	1.59%	$53.15M
Frazier life sciences management	4.62M	0.75%	$16.09M
Highvista strategies	518.82K	0.66%	$1.81M
Avoro capital advisors	12.35M	0.57%	$42.96M
Healthinvest partners ab	226.15K	0.48%	$786.98K
Blackstone	20.49M	0.30%	$71.29M

Top Buyers

Holder	Shares	% Assets	Change
Wellington management group llp	17.89M	0.01%	7.13M
Fmr	12.30M	0.00%	3.28M
Great point partners	3.44M	2.29%	2.27M
Morgan stanley	2.90M	0.00%	2.21M
Armistice capital	6.25M	0.27%	1.58M

Top Sellers

Holder	Shares	% Assets	Change
Cormorant asset management, lp	-	-	-6.62M
Paradigm biocapital advisors lp	-	-	-6.43M
Perceptive advisors	-	-	-4.33M
Lynx1 capital management lp	-	-	-1.39M
Commodore capital lp	-	-	-1.18M

New Positions

Holder	Shares	% Assets	Change	Value
Eversept partners, lp	610.90K	0.15%	610.90K	$2.13M
Vontobel	207.10K	0.00%	207.10K	$720.70K
Clearstead advisors	96.11K	0.01%	96.11K	$334.45K
Mitsubishi ufj kokusai asset management	74.40K	0.00%	74.40K	$258.90K
Legal & general group	60.51K	-	60.51K	$210.88K

Sold Out

Holder	Change
Cubist systematic strategies	-160.00
Carmichael hill & associates	-254.00
Lazard asset management	-483.00
Aquatic capital management	-3.10K
Itau unibanco	-3.76K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	99	-10.00%	178,343,707	0.33%	67	1.05%	36	-33.33%	35	20.69%
Jun 30, 2024	110	-9.09%	177,754,578	1.37%	80	1.28%	54	-23.94%	29	7.41%
Mar 31, 2024	121	23.47%	175,349,129	51.63%	78	1.79%	71	36.54%	27	28.57%
Dec 31, 2023	98	42.03%	115,642,954	4.62%	66	1.65%	52	116.67%	21	-12.50%
Sep 30, 2023	69	-	110,531,704	1.28%	63	1.61%	24	-29.41%	24	71.43%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Syncona Ord	30.73M	11.55%	9.39M
Vanguard Health Care Inv	19.36M	7.27%	5.82M
FIAM Small Cap Core CIT Cl B	3.39M	1.27%	47.04K
FIAM Small Cap Core Composite	3.31M	1.24%	1.78M
Fidelity Advisor Biotechnology I	3.01M	1.13%	-
Fidelity Small Cap Growth	2.57M	0.97%	-6.73K
Fidelity Series Small Cap Opps	2.51M	0.94%	-109.20K
US Small-Cap Growth II Equity Comp	2.27M	0.85%	-8.06K
T. Rowe Price New Horizons	2.27M	0.85%	-7.15K
Fidelity Stock Selector Small Cap	1.71M	0.64%	37.00K

AUTL Ownership FAQ

Who Owns Autolus Therapeutics?

Autolus Therapeutics shareholders are primarily institutional investors at 67.03%, followed by 18.09% insiders and 14.88% retail investors. The average institutional ownership in Autolus Therapeutics's industry, Biotech Stocks , is 47.04%, which Autolus Therapeutics exceeds.

Who owns the most shares of Autolus Therapeutics?

Autolus Therapeutics’s largest shareholders are Syncona portfolio (21.35M shares, 9.61%), Blackstone (20.49M shares, 9.22%), and Wellington management group llp (17.89M shares, 8.05%). Together, they hold 26.88% of Autolus Therapeutics’s total shares outstanding.

Does Blackrock own Autolus Therapeutics?

Yes, BlackRock owns 2.00% of Autolus Therapeutics, totaling 4.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 15.44M$. In the last quarter, BlackRock increased its holdings by 380.18K shares, a 9.37% change.

Who is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested, with 86.51% of its assets in 21.35M Autolus Therapeutics shares, valued at 74.29M$.

Who is the top mutual fund holder of Autolus Therapeutics shares?

Syncona Ord is the top mutual fund holder of Autolus Therapeutics shares, with 11.55% of its total shares outstanding invested in 30.73M Autolus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools